Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 5.19M
2: EX-4.3 Instrument Defining the Rights of Security Holders HTML 52K
3: EX-4.4 Instrument Defining the Rights of Security Holders HTML 136K
4: EX-10.28 Material Contract HTML 105K
5: EX-10.29 Material Contract HTML 41K
6: EX-10.78 Material Contract HTML 67K
7: EX-10.79 Material Contract HTML 71K
8: EX-10.80 Material Contract HTML 53K
9: EX-10.81 Material Contract HTML 44K
10: EX-10.85 Material Contract HTML 67K
11: EX-10.86 Material Contract HTML 70K
12: EX-10.87 Material Contract HTML 67K
13: EX-21 Subsidiaries List HTML 149K
14: EX-23 Consent of Expert or Counsel HTML 38K
15: EX-31.1 Certification -- §302 - SOA'02 HTML 41K
16: EX-31.2 Certification -- §302 - SOA'02 HTML 41K
17: EX-32.1 Certification -- §906 - SOA'02 HTML 38K
18: EX-32.2 Certification -- §906 - SOA'02 HTML 38K
24: R1 Cover Page HTML 185K
25: R2 Audit Information HTML 42K
26: R3 Consolidated Statements of Earnings HTML 122K
27: R4 Consolidated Statements of Comprehensive Earnings HTML 88K
28: R5 Consolidated Statements of Comprehensive Earnings HTML 51K
(Parenthetical)
29: R6 Consolidated Balance Sheets HTML 205K
30: R7 Consolidated Balance Sheets (Parenthetical) HTML 52K
31: R8 Consolidated Statements of Cash Flows HTML 145K
32: R9 Consolidated Statements of Cash Flows HTML 43K
(Parenthetical)
33: R10 Consolidated Statements of Stockholders' (Deficit) HTML 93K
Equity
34: R11 Consolidated Statements of Stockholders' (Deficit) HTML 39K
Equity (Parenthetical)
35: R12 Consolidated Statements of Earnings HTML 43K
(Parenthetical)
36: R13 Background and Basis of Presentation HTML 47K
37: R14 Summary of Significant Accounting Policies HTML 63K
38: R15 Acquisitions HTML 89K
39: R16 War in Ukraine HTML 54K
40: R17 Goodwill and Other Intangible Assets, net HTML 109K
41: R18 Related Parties - Equity Investments and Other HTML 72K
42: R19 Product Warranty HTML 48K
43: R20 Indebtedness HTML 197K
44: R21 Capital Stock HTML 55K
45: R22 Stock Plans HTML 115K
46: R23 Earnings per Share HTML 54K
47: R24 Income Taxes HTML 133K
48: R25 Segment Reporting HTML 184K
49: R26 Benefit Plans HTML 373K
50: R27 Additional Information HTML 55K
51: R28 Financial Instruments HTML 154K
52: R29 Accumulated Other Comprehensive Losses HTML 53K
53: R30 Contingencies HTML 168K
54: R31 Sale of Accounts Receivable HTML 41K
55: R32 Asset Impairment and Exit Costs HTML 71K
56: R33 Leases HTML 115K
57: R34 Summary of Significant Accounting Policies HTML 114K
(Policy)
58: R35 Acquisitions (Tables) HTML 67K
59: R36 War in Ukraine (Tables) HTML 49K
60: R37 Goodwill and Other Intangible Assets, net (Tables) HTML 131K
61: R38 Related Parties - Equity Investments and Other HTML 64K
(Tables)
62: R39 Product Warranty (Tables) HTML 47K
63: R40 Indebtedness (Tables) HTML 200K
64: R41 Capital Stock (Tables) HTML 57K
65: R42 Stock Plans (Tables) HTML 114K
66: R43 Earnings per Share (Tables) HTML 52K
67: R44 Income Taxes (Tables) HTML 130K
68: R45 Segment Reporting (Tables) HTML 167K
69: R46 Benefit Plans (Tables) HTML 377K
70: R47 Additional Information (Tables) HTML 54K
71: R48 Financial Instruments (Tables) HTML 146K
72: R49 Accumulated Other Comprehensive Losses (Tables) HTML 50K
73: R50 Contingencies (Tables) HTML 73K
74: R51 Asset Impairment and Exit Costs (Tables) HTML 68K
75: R52 Leases (Tables) HTML 120K
76: R53 Summary of Significant Accounting Policies HTML 45K
(Details)
77: R54 Acquisitions (Details) HTML 194K
78: R55 Acquisitions (Swedish Match AB) (Details) HTML 134K
79: R56 Acquisitions (Pro Forma) (Details) HTML 43K
80: R57 War in Ukraine (Details) HTML 87K
81: R58 Goodwill and Other Intangible Assets, net HTML 79K
(Movement in Goodwill) (Details)
82: R59 Goodwill and Other Intangible Assets, net (Other HTML 65K
Intangible Assets) (Details)
83: R60 Goodwill and Other Intangible Assets, net HTML 92K
(Narrative) (Details)
84: R61 Related Parties - Equity Investments and Other HTML 91K
(Narrative) (Details)
85: R62 Related Parties - Equity Investments and Other HTML 56K
(Balance Sheet and Earnings Activity) (Details)
86: R63 Product Warranty (Details) HTML 51K
87: R64 Indebtedness (Short-Term Borrowings) (Details) HTML 49K
88: R65 Indebtedness (Long-Term Debt) (Details) HTML 76K
89: R66 Indebtedness (Fair Value of Outstanding Long-Term HTML 44K
Debt, Excluding Finance Leases) (Details)
90: R67 Indebtedness (Debt Issuances Outstanding) HTML 200K
(Details)
91: R68 Indebtedness (Narrative) (Details) HTML 125K
92: R69 Indebtedness (Aggregate Maturities of Long-Term HTML 64K
Debt) (Details)
93: R70 Indebtedness (Credit Facilities) (Details) HTML 49K
94: R71 Capital Stock (Narrative) (Details) HTML 63K
95: R72 Capital Stock (Schedule of Common Stock) (Details) HTML 60K
96: R73 Stock Plans (Narrative) (Details) HTML 90K
97: R74 Stock Plans (Activity for Restricted Share Unit HTML 73K
Awards) (Details)
98: R75 Stock Plans (Activity for Performance Share Units) HTML 86K
(Details)
99: R76 Stock Plans (Assumptions Used) (Details) HTML 42K
100: R77 Earnings per Share (Details) HTML 72K
101: R78 Income Taxes (Schedule of Earnings Before Income HTML 64K
Taxes and Provision For Income Taxes) (Details)
102: R79 Income Taxes (Narrative) (Details) HTML 74K
103: R80 Income Taxes (Schedule of Reconciliation of HTML 53K
Unrecognized Tax Benefits) (Details)
104: R81 Income Taxes (Schedule of Unrecognized Tax HTML 45K
Benefits and Liability for Contingent Income
Taxes, Interest and Penalties) (Details)
105: R82 Income Taxes (Schedule of Reasons Attributable to HTML 61K
the Differences Between Effective Income Tax Rate
And Federal Statutory Rate) (Details)
106: R83 Income Taxes (Schedule of Temporary Differences of HTML 79K
Tax Effects to Deferred Income Tax Assets and
Liabilities) (Details)
107: R84 Segment Reporting (Narrative) (Details) HTML 104K
108: R85 Segment Reporting (Segment Data) (Details) HTML 94K
109: R86 Segment Reporting (Other Expenses By Segment) HTML 63K
(Details)
110: R87 Segment Reporting (Long-Lived Assets By Segment) HTML 63K
(Details)
111: R88 Benefit Plans (Pension and Other Employee Benefit HTML 47K
Costs) (Details)
112: R89 Benefit Plans (Obligations and Funded Status) HTML 102K
(Details)
113: R90 Benefit Plans (Narrative) (Details) HTML 91K
114: R91 Benefit Plans (Pension and Postretirement HTML 55K
Liabilities Recognized in Consolidated Balance
Sheet) (Details)
115: R92 Benefit Plans (Weighted-Average Assumptions to HTML 53K
Determine Benefit Obligations) (Details)
116: R93 Benefit Plans (Components of Net Periodic Benefit HTML 71K
Cost) (Details)
117: R94 Benefit Plans (Net Pension and Postretirement Cost HTML 55K
Weighted-Average Assumptions) (Details)
118: R95 Benefit Plans (Fair Value of Pension Plan Assets) HTML 114K
(Details)
119: R96 Benefit Plans (Estimated Future Benefit Payments HTML 51K
From Pension Plans) (Details)
120: R97 Benefit Plans (Amounts Recorded in Accumulated HTML 62K
Other Comprehensive Losses) (Details)
121: R98 Benefit Plans (Movements in Other Comprehensive HTML 102K
Earnings (Losses)) (Details)
122: R99 Additional Information (Details) HTML 53K
123: R100 Financial Instruments (Narrative) (Details) HTML 52K
124: R101 Financial Instruments (Notional Amounts of HTML 47K
Outstanding Derivative Instruments) (Details)
125: R102 Financial Instruments (Fair Value of Foreign HTML 84K
Exchange Contracts) (Details)
126: R103 Financial Instruments (Cash Flow and Net HTML 82K
Investment Hedging Activities Effect on Condensed
Consolidated Statements of Earnings and Other
Comprehensive Earnings) (Details)
127: R104 Financial Instruments (Hedging Activity Affect on HTML 48K
AOCI) (Details)
128: R105 Accumulated Other Comprehensive Losses (Components HTML 58K
of Accumulated Other Comprehensive Losses, Net Of
Taxes) (Details)
129: R106 Contingencies (Tobacco-Related Litigation) HTML 116K
(Details)
130: R107 Contingencies (Number of Tobacco Related Cases HTML 53K
Pertaining to Combustible Products Pending Against
Us and/or Our Subsidiaries or Indemnitees)
(Details)
131: R108 Contingencies (Verdicts and Post-Trial HTML 81K
Developments) (Details)
132: R109 Contingencies (Smoking and Health Litigation) HTML 59K
(Details)
133: R110 Contingencies (Health Care Cost Recovery HTML 78K
Litigation) (Details)
134: R111 Contingencies (Label-Related Cases) (Details) HTML 45K
135: R112 Contingencies (Public Civil Actions) (Details) HTML 43K
136: R113 Contingencies (Other Litigation) (Details) HTML 91K
137: R114 Contingencies (Third-Party Guarantees) (Details) HTML 46K
138: R115 Sale of Accounts Receivable (Details) HTML 43K
139: R116 Asset Impairment and Exit Costs (Narrative) HTML 70K
(Details)
140: R117 Asset Impairment and Exit Costs (Asset Impairment HTML 68K
and Exit Costs by Segment) (Details)
141: R118 Asset Impairment and Exit Costs (Movement in Exit HTML 47K
Cost Liabilities) (Details)
142: R119 Leases (Balance Sheet Classification of Lease HTML 80K
Assets and Liabilities) (Details)
143: R120 Leases (Lease Cost) (Details) HTML 51K
144: R121 Leases (Maturities of Operating and Finance Lease HTML 78K
Liabilities) (Details)
145: R122 Leases (Other Lease Information) (Details) HTML 57K
148: XML IDEA XML File -- Filing Summary XML 277K
146: XML XBRL Instance -- pm-20221231_htm XML 6.69M
147: EXCEL IDEA Workbook of Financial Reports XLSX 329K
20: EX-101.CAL XBRL Calculations -- pm-20221231_cal XML 400K
21: EX-101.DEF XBRL Definitions -- pm-20221231_def XML 1.81M
22: EX-101.LAB XBRL Labels -- pm-20221231_lab XML 3.72M
23: EX-101.PRE XBRL Presentations -- pm-20221231_pre XML 2.38M
19: EX-101.SCH XBRL Schema -- pm-20221231 XSD 411K
149: JSON XBRL Instance as JSON Data -- MetaLinks 843± 1.32M
150: ZIP XBRL Zipped Folder -- 0001413329-23-000025-xbrl Zip 1.82M
1.I have reviewed this annual report on Form 10-K of Philip Morris International Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the
registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting.
